Skip to main content
Veterinary Medicines

Bayer Dog Tasty Bone XL 525/504/175 mg tablets

Authorised
  • Febantel
  • Pyrantel embonate
  • Praziquantel

Product identification

Medicine name:
Bayer Dog Tasty Bone XL 525/504/175 mg tablets
Mansonil All Worm Large Dog Tasty 525/504/175 mg tabletten
Active substance:
  • Febantel
  • Pyrantel embonate
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    525.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    504.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    175.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container sizes: Cartons containing 2 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 119740
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0336/002
Concerned member states:
  • France
  • Netherlands

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 26/01/2022

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."